Back to MF Merit Financial Group, LLC
IBRX
14 quarters
Position history for MFMerit Financial Group, LLC's holdings in ImmunityBio, Inc.
Yes. Merit Financial Group holds 47,916 shares of IBRX (ImmunityBio), worth $419,505, as of its Q2 2026 13F filing. It increased the position by 3,351 shares (+7.5%) from Q1 2026. Merit Financial Group has held IBRX since Q1 2023, across 14 quarterly 13F filings.
Current Value
$419,505
Current Shares
47,916
Total Value Change
+$376,189
Total Shares Change
+24,116
Quarter-by-Quarter History
Other major holders of IBRX: BlackRock, Inc., State Street Corp., Vanguard Portfolio Management LLC, Vanguard Capital Management LLC